Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zurex Pharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
Zurex Pharma

Zurex Pharma

Series A

Zurex Pharma Inc. develops specialty pharmaceuticals and medical tech to prevent healthcare infections.

HQ
Middleton, WI, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to combat healthcare-acquired infections, Zurex Pharma Inc. is a specialty pharmaceutical and medical technology company. The organization focuses on developing and commercializing antimicrobial products aimed at infection prevention. Their product portfolio includes solutions like pre-surgical skin preparation and catheter infection prevention products, with a notable offering being ZuraGard, which enhances the efficiency and effectiveness of skin antisepsis.

Zurex Pharma has garnered attention for its innovative approach to infection control, attracting investment from notable healthcare investors. The company's achievements include the successful development and market introduction of ZuraGard, which has been praised for its rapid application and effectiveness. By addressing critical needs in healthcare settings, Zurex Pharma has made a significant impact on patient safety and operational efficiency in medical environments.

Zurex Pharma - Similar Companies

ZSX Medical logo

ZSX Medical

zsxmedical.com

Zocere logo

Zocere

zocere.com

Zymeron logo

Zymeron

zymeron.com

Zylast logo

Zylast

zylast.com

Prevacept Infection Control logo

Prevacept Infection Control

ZetaRx Biosciences logo

ZetaRx Biosciences

Curza logo

Curza

curza.com

Izun Pharmaceuticals logo

Izun Pharmaceuticals

izunpharma.com

Sterifre Medical logo

Sterifre Medical

sterifre.com

Zerigo Health logo

Zerigo Health

zerigohealth.com

Zabecor Pharmaceuticals logo

Zabecor Pharmaceuticals

Baudax Bio logo

Baudax Bio

Clozex Medical logo

Clozex Medical

clozex.com

Zaina Pharma logo

Zaina Pharma

Zai Lab logo

Zai Lab

zailaboratory.com

Zurex Pharma - Quick Facts

Who are Zurex Pharma's competitors?

Companies similar to Zurex Pharma include ZSX Medical, Zocere, Zymeron and Zylast.

When was Zurex Pharma founded?

Zurex Pharma was founded in 2010.

Where is Zurex Pharma's headquarters located?

Zurex Pharma's headquarters is located in Middleton, WI, US.

When was Zurex Pharma's last funding round?

Zurex Pharma's most recent funding round was for $3.8M (USD) in December 2023.

How much has Zurex Pharma raised to-date?

As of Dec 28, 2023, Zurex Pharma has raised a total of $38.7M (USD).

How many employees does Zurex Pharma have?

Zurex Pharma has 35 employees as of Feb 5, 2024.

Zurex Pharma - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research